World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 82 16106 15155 843 813 380 24959

Bernd Dörken publications per year

The chart shows the history of publications by Bernd Dörken between 1980 and 2023, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Bernd Dörken published across 44 years, from 1980 to 2023, averaging 9.4 papers a year. Output peaked at 30 publications in 2005. 28 of the 415 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1980 to 2023. Vertical axis: number of publications, 0 to 30. Peak 30 publications in 2005. 1980: 1 publication 1981: 0 publications 1982: 0 publications 1983: 2 publications 1984: 0 publications 1985: 1 publication 1986: 2 publications 1987: 3 publications 1988: 3 publications 1989: 2 publications 1990: 0 publications 1991: 1 publication 1992: 1 publication 1993: 2 publications 1994: 2 publications 1995: 1 publication 1996: 4 publications 1997: 13 publications 1998: 2 publications 1999: 6 publications 2000: 5 publications 2001: 6 publications 2002: 12 publications 2003: 7 publications 2004: 16 publications 2005: 30 publications 2006: 25 publications 2007: 18 publications 2008: 22 publications 2009: 20 publications 2010: 24 publications 2011: 30 publications 2012: 22 publications 2013: 25 publications 2014: 24 publications 2015: 21 publications 2016: 17 publications 2017: 10 publications 2018: 6 publications 2019: 1 publication 2020: 0 publications 2021: 0 publications 2022: 0 publications 2023: 28 publications
1980 2023

415 publications in total across all disciplines

View publications per year as a table
Bernd Dörken: publications per year, 1980 to 2023
Year Publications
1980 1
1981 0
1982 0
1983 2
1984 0
1985 1
1986 2
1987 3
1988 3
1989 2
1990 0
1991 1
1992 1
1993 2
1994 2
1995 1
1996 4
1997 13
1998 2
1999 6
2000 5
2001 6
2002 12
2003 7
2004 16
2005 30
2006 25
2007 18
2008 22
2009 20
2010 24
2011 30
2012 22
2013 25
2014 24
2015 21
2016 17
2017 10
2018 6
2019 1
2020 0
2021 0
2022 0
2023 28
Total 415
Download as CSV

Bernd Dörken publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Bernd Dörken sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 361–380 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 380 publications — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838 380
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Bernd Dörken D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Bernd Dörken sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 82–83 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 82 D-Index — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027 82
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Bernd Dörken is affiliated with Charité - University Medicine Berlin in Germany. Their research spans several interconnected fields within biomedical science, with a focus on both clinical and molecular aspects of disease.

The main fields of study explored by Dörken include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Dörken's work also extends into specialized subfields such as:

  • Hematology
  • Molecular Biology
  • Oncology

The scientist addresses multiple research topics, particularly within cancer biology and treatment, including:

  • Acute Myeloid Leukemia Research
  • Multiple Myeloma Research and Treatments
  • Histone Deacetylase Inhibitors Research
  • Cancer-related Molecular Pathways
  • Pancreatic and Hepatic Oncology Research
  • RNA modifications and cancer

Dörken has contributed to recent publications, including:

  • "Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study," 2023, Annals of Hematology
  • "Withdrawal: p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase activity," 2023, Journal of Biological Chemistry

The scientist often collaborates with other researchers in their field. Frequent co-authors include:

  • Dietger Niederwieser
  • Thomas Lang
  • Rainer Krahl
  • Thomas Heinicke
  • Georg Maschmeyer

Dörken's publications have appeared primarily in the following venues:

  • Annals of Hematology
  • Journal of Biological Chemistry

Best Publications

  • Oncogene-induced senescence as an initial barrier in lymphoma development

    Melanie Braig;Soyoung Lee;Christoph Loddenkemper;Cornelia Rudolph

  • Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

    Volker Diehl;Jeremy Franklin;Michael Pfreundschuh;Bernd Lathan

  • Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

    Andreas Engert;Annette Plütschow;Hans Theodor Eich;Andreas Lohri

  • Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

    R C Bargou;F Emmerich;D Krappmann;K Bommert

  • Clinical Experiences with Magnetic Drug Targeting: A Phase I Study with 4′-Epidoxorubicin in 14 Patients with Advanced Solid Tumors

    Andreas Stephan Lübbe;Christian Bergemann;Hanno Riess;Folke Schriever

  • Senescence-associated reprogramming promotes cancer stemness

    Maja Milanovic;Dorothy N. Y. Fan;Dimitri Belenki;J. Henry M. Däbritz

  • Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

    Andreas Engert;Heinz Haverkamp;Carsten Kobe;Jana Markova

  • Synthetic lethal metabolic targeting of cellular senescence in cancer therapy

    Jan R. Dörr;Yong Yu;Maja Milanovic;Gregor Beuster

  • Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma

    Franziska Jundt;Ioannis Anagnostopoulos;Reinhold Förster;Stephan Mathas

  • Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: a phase III-study from the German CONKO-study group.

    Uwe Pelzer;Ingo Schwaner;Jens Stieler;Mathias Adler

  • Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma

    Rami Rahal;Mareike Frick;Rodrigo Romero;Joshua M Korn

  • Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma

    Björn Lamprecht;Korden Walter;Stephan Kreher;Stephan Kreher;Raman Kumar

  • PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma

    Matthias Pfeifer;Michael Grau;Dido Lenze;Sören-Sebastian Wenzel

  • Malt1-dependent RelB cleavage promotes canonical NF-κB activation in lymphocytes and lymphoma cell lines

    Stephan Hailfinger;Hendrik Nogai;Christiane Pelzer;Maike Jaworski

  • Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)

    Stephan H.K. Oertel;Erik Verschuuren;Petra Reinke;Kristin Zeidler

  • Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells.

    Franziska Jundt;Kristina Schulze Pröbsting;Ioannis Anagnostopoulos;Gwendolin Muehlinghaus

  • CONKO-005: Adjuvant Chemotherapy With Gemcitabine Plus Erlotinib Versus Gemcitabine Alone in Patients After R0 Resection of Pancreatic Cancer: A Multicenter Randomized Phase III Trial

    Marianne Sinn;Marcus Bahra;Torsten Liersch;Klaus Gellert

  • Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib

    T D Kim;D Rea;M Schwarz;P Grille

  • Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.

    R C Bargou;C Wagener;K Bommert;M Y Mapara

  • Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

    Stephan Mathas;Martin Janz;Martin Janz;Franziska Hummel;Michael Hummel

Frequent Co-Authors

Peter T. Daniel
Peter T. Daniel Max Delbrück Center for Molecular Medicine
Michael Hummel
Michael Hummel Charité - University Medicine Berlin
Ioannis Anagnostopoulos
Ioannis Anagnostopoulos Charité - University Medicine Berlin
Harald Stein
Harald Stein Charité - University Medicine Berlin
Thomas Blankenstein
Thomas Blankenstein Max Delbrück Center for Molecular Medicine
Martin Lipp
Martin Lipp Max Delbrück Center for Molecular Medicine
Christoph Loddenkemper
Christoph Loddenkemper Charité - University Medicine Berlin
Claus Scheidereit
Claus Scheidereit Max Delbrück Center for Molecular Medicine
Petra Reinke
Petra Reinke Berlin-Brandenburger Centrum für Regenerative Therapien

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA can also mean exploring alternative pathways and online programs. Many students start by earning a nursing degree, as becoming a Registered Nurse (RN) remains a popular entry route. For those looking to advance quickly and affordably, researching what is the cheapest rn to bsn program online can help minimize costs without sacrificing quality.

If you hold a non-nursing bachelor’s degree but wish to enter advanced practice nursing, direct entry msn programs allow a faster transition, making it possible to enter the field with flexibility and minimal prerequisites.

Those concerned about admissions difficulty can consider nursing programs with high acceptance rates, which offer more accessible entry points and can help open doors to a healthcare career.

Healthcare isn’t limited to clinical roles—fields like medical billing and coding are also in high demand. There are options for individuals seeking administrative careers, with many accredited programs offering financial support, as detailed in financial aid for medical billing and coding.

Best Scientists Citing Bernd Dörken

Trending Scientists

Recently Published Articles